Yan Yin's Form 4 filing
Bio Essence Corp (BIOE) · filed Oct 10, 2024
- Accession no.
- 0001213900-24-087036
- Filed
- Oct 10, 2024
- Trade date
- Sep 25-30, 2024
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $106.8K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yan YinCIK 0001990397 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Common Stock | SSaleDisposed | −50,000 | $0.70 | −$35,000 | 13,726,035 | Direct | |
| Sep 26, 2024 | Common Stock | SSaleDisposed | −40,000 | $1.67 | −$66,800 | 13,686,035 | Direct | |
| Sep 27, 2024 | Common Stock | SSaleDisposed | −200 | $1.69 | −$338 | 13,685,835 | Direct | |
| Sep 30, 2024 | Common stock | SSaleDisposed | −1,990 | $2.35 | −$4,676.5 | 13,683,845 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.